Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men.

McDonnell J, Haddow L, Daskalopoulou M, Lampe F, Speakman A, Gilson R, Phillips A, Sherr L, Wayal S, Harrison J, Antinori A, Maruff P, Schembri A, Johnson M, Collins S, Rodger A; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):120-7. doi: 10.1097/QAI.0000000000000273.

2.

HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.

Kelly CM, van Oosterhout JJ, Ngwalo C, Stewart RC, Benjamin L, Robertson KR, Khoo S, Allain TJ, Solomon T.

PLoS One. 2014 Jun 10;9(6):e98962. doi: 10.1371/journal.pone.0098962. eCollection 2014.

3.

Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study.

Rawson TM, Dubb S, Pozniak A, Kelleher WP, Mandalia S, Gazzard B, Barber TJ.

Int J STD AIDS. 2015 Feb;26(2):128-32. doi: 10.1177/0956462414531934. Epub 2014 Apr 22.

PMID:
24759562
4.

Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000-13: a serial cross-sectional study.

Aghaizu A, Wayal S, Nardone A, Parsons V, Copas A, Mercey D, Hart G, Gilson R, Johnson AM.

Lancet HIV. 2016 Sep;3(9):e431-e440. doi: 10.1016/S2352-3018(16)30037-6. Epub 2016 Jul 14.

PMID:
27562744
5.

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Wright EJ, Grund B, Cysique LA, Robertson KR, Brew BJ, Collins G, Shlay JC, Winston A, Read TR, Price RW; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:97-108. doi: 10.1111/hiv.12238.

6.

Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.

Lawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, Nthobatsang R, Steenhoff A.

J Int AIDS Soc. 2010 Apr 20;13:15. doi: 10.1186/1758-2652-13-15.

7.

Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada.

Robertson K, Bayon C, Molina JM, McNamara P, Resch C, Muñoz-Moreno JA, Kulasegaram R, Schewe K, Burgos-Ramirez A, De Alvaro C, Cabrero E, Guion M, Norton M, van Wyk J.

AIDS Care. 2014;26(12):1555-61. doi: 10.1080/09540121.2014.936813. Epub 2014 Jul 16.

8.

Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre.

Haddow LJ, Accoroni A, Cartledge JD, Manji H, Benn P, Gilson RJ.

Int J STD AIDS. 2013 Mar;24(3):217-9. doi: 10.1177/0956462412472452. Epub 2013 May 6.

9.

HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research.

Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, Hubner E, Carr A, Brew BJ.

J Neurovirol. 2014 Jun;20(3):258-68. doi: 10.1007/s13365-014-0242-x. Epub 2014 Apr 3.

10.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I; CHARTER Group.

Neurology. 2010 Dec 7;75(23):2087-96. doi: 10.1212/WNL.0b013e318200d727.

11.

What are the risk factors for HIV in men who have sex with men in Ho Chi Minh City, Vietnam?- A cross-sectional study.

Le TM, Lee PC, Stewart DE, Long TN, Quoc CN.

BMC Public Health. 2016 May 16;16:406. doi: 10.1186/s12889-016-3088-8.

12.

Depression and diagnosis of neurocognitive impairment in HIV-positive patients.

Pinheiro CA, Souza LD, Motta JV, Kelbert EF, Souza MS, Martins CS, Coelho FM, Pinheiro KA, Pinheiro RT.

Braz J Med Biol Res. 2016 Sep 12;49(10):e5344. doi: 10.1590/1414-431X20165344.

13.

Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort.

Moore DJ, Roediger MJ, Eberly LE, Blackstone K, Hale B, Weintrob A, Ganesan A, Agan BK, Letendre SL, Crum-Cianflone NF.

PLoS One. 2012;7(11):e47310. doi: 10.1371/journal.pone.0047310. Epub 2012 Nov 8.

14.

HIV prevalence and factors associated with HIV infection among men who have sex with men in Cameroon.

Park JN, Papworth E, Kassegne S, Moukam L, Billong SC, Macauley I, Yomb YR, Nkoume N, Mondoleba V, Eloundou J, LeBreton M, Tamoufe U, Grosso A, Baral SD.

J Int AIDS Soc. 2013 Dec 2;16 Suppl 3:18752. doi: 10.7448/IAS.16.4.18752.

15.

High Prevalence of HIV Infection and Bisexual Networks among a Sample of Men Who Have Sex with Men in Eastern China.

Lin H, Ding Y, Liu X, Wu Q, Shen W, He N.

PLoS One. 2015 Jun 8;10(6):e0129300. doi: 10.1371/journal.pone.0129300. eCollection 2015.

16.
17.

Cognitive disorders in HIV-infected patients: are they HIV-related?

Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy FA, Mercié P, Greib C, Richert L, Neau D, Catheline G, Dehail P, Dabis F, Morlat P, Dartigues JF, Chêne G; S CO3 Aquitaine Cohort.

AIDS. 2013 Jan 28;27(3):391-400. doi: 10.1097/QAD.0b013e32835b1019.

PMID:
23079813
18.

Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.

Crum-Cianflone NF, Moore DJ, Letendre S, Poehlman Roediger M, Eberly L, Weintrob A, Ganesan A, Johnson E, Del Rosario R, Agan BK, Hale BR.

Neurology. 2013 Jan 22;80(4):371-9. doi: 10.1212/WNL.0b013e31827f0776. Epub 2013 Jan 9.

19.

Effects of smoking and alcohol use on neurocognitive functioning in heavy drinking, HIV-positive men who have sex with men.

Monnig MA, Kahler CW, Lee H, Pantalone DW, Mayer KH, Cohen RA, Monti PM.

AIDS Care. 2016;28(3):300-5. doi: 10.1080/09540121.2015.1093595. Epub 2015 Oct 7.

20.

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, Tamburrini E, Cauda R, De Luca A, Silveri MC.

Neurology. 2011 Apr 19;76(16):1403-9. doi: 10.1212/WNL.0b013e31821670fb.

PMID:
21502598

Supplemental Content

Support Center